WHO project focuses on strengthening pharmacovigilance
This article was originally published in SRA
The World Health Organization has announced the launch of a major international project on “Optimizing Drug Safety Monitoring to Enhance Patient Safety and Achieve Better Health Outcomes”1.
You may also be interested in...
The Canadian authorities have put in place an expedited pathway for authorizing new COVID-19 drugs and vaccines that offers a more agile approach to reviewing data than what was previously allowed.
A new pre-assessment service for COVID-19 clinical trials that was established by the UK medicines regulator to cut down on review times is being extended to a limited number of other kinds of trials.
The European Medicines Agency is developing a strategy to ensure that women have sufficient information to make informed choices about taking medicines during pregnancy and breastfeeding.